BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26660322)

  • 1. Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation.
    Bernardo BC; Sapra G; Patterson NL; Cemerlang N; Kiriazis H; Ueyama T; Febbraio MA; McMullen JR
    PLoS One; 2015; 10(12):e0145173. PubMed ID: 26660322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
    Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
    Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Heat Shock Protein 70 Improves Cardiac Remodeling and Survival in Protein Phosphatase 2A-Expressing Transgenic Mice with Chronic Heart Failure.
    Yoon S; Gergs U; McMullen JR; Eom GH
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance.
    Ogata T; Ueyama T; Isodono K; Tagawa M; Takehara N; Kawashima T; Harada K; Takahashi T; Shioi T; Matsubara H; Oh H
    Mol Cell Biol; 2008 May; 28(10):3424-36. PubMed ID: 18332105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin-Induced Heart Failure Through Resolution of Toll-Like Receptor 2-Mediated Myocardial Inflammation.
    Liu P; Bao HY; Jin CC; Zhou JC; Hua F; Li K; Lv XX; Cui B; Hu ZW; Zhang XW
    J Am Heart Assoc; 2019 Oct; 8(20):e012338. PubMed ID: 31576776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of heat shock protein 70 (Hsp70) in atrial fibrillation in various cardiomyopathy conditions.
    Min TJ; Jo WM; Shin SY; Lim HE
    Heart Vessels; 2015 May; 30(3):379-85. PubMed ID: 24890362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.
    Cardin S; Guasch E; Luo X; Naud P; Le Quang K; Shi Y; Tardif JC; Comtois P; Nattel S
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):1027-35. PubMed ID: 22923342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.
    Naka K K; Vezyraki P; Kalaitzakis A; Zerikiotis S; Michalis L; Angelidis C
    Cell Stress Chaperones; 2014 Nov; 19(6):853-64. PubMed ID: 24748476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice.
    Sapra G; Tham YK; Cemerlang N; Matsumoto A; Kiriazis H; Bernardo BC; Henstridge DC; Ooi JY; Pretorius L; Boey EJ; Lim L; Sadoshima J; Meikle PJ; Mellet NA; Woodcock EA; Marasco S; Ueyama T; Du XJ; Febbraio MA; McMullen JR
    Nat Commun; 2014 Dec; 5():5705. PubMed ID: 25489988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B
    Lottonen-Raikaslehto L; Rissanen R; Gurzeler E; Merentie M; Huusko J; Schneider JE; Liimatainen T; Ylä-Herttuala S
    Physiol Rep; 2017 Mar; 5(6):. PubMed ID: 28351964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrosis and the mechanisms of atrial fibrillation.
    Everett TH; Olgin JE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S24-7. PubMed ID: 17336879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP70: therapeutic potential in acute and chronic cardiac disease settings.
    Bernardo BC; Weeks KL; Patterson NL; McMullen JR
    Future Med Chem; 2016 Dec; 8(18):2177-2183. PubMed ID: 27845575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of heat shock response protects the heart against atrial fibrillation.
    Brundel BJ; Shiroshita-Takeshita A; Qi X; Yeh YH; Chartier D; van Gelder IC; Henning RH; Kampinga HH; Nattel S
    Circ Res; 2006 Dec; 99(12):1394-402. PubMed ID: 17110598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.
    Ozcan C; Battaglia E; Young R; Suzuki G
    J Am Heart Assoc; 2015 Mar; 4(3):e001733. PubMed ID: 25773299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic HDAC6 Activation Induces Atrial Fibrillation Through Atrial Electrical and Structural Remodeling in Transgenic Mice.
    Sawa Y; Matsushita N; Sato S; Ishida N; Saito M; Sanbe A; Morino Y; Taira E; Obara M; Hirose M
    Int Heart J; 2021; 62(3):616-626. PubMed ID: 34054002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation.
    Dawson K; Wakili R; Ordög B; Clauss S; Chen Y; Iwasaki Y; Voigt N; Qi XY; Sinner MF; Dobrev D; Kääb S; Nattel S
    Circulation; 2013 Apr; 127(14):1466-75, 1475e1-28. PubMed ID: 23459615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: effects beyond the atrium?
    Wijesurendra RS; Casadei B
    Cardiovasc Res; 2015 Mar; 105(3):238-47. PubMed ID: 25587048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.